Market Introduction
Urinary tract infections (UTIs) are more common among women than in men. These infections are easy to cure; however, the untreated cases may lead to a severe health conditions. There are various UTI diagnostics kits available in the market, and these are sold over the counter. The functioning of UTI diagnostics is similar to the pregnancy kits; a strip provided in the kit is held in urine stream for a few seconds or dipped into a sample collected in a clean cup. The rising number of UTI cases is leading to the increase in demand for the home diagnostics kits. In addition, the awareness regarding kits is likely to boost the market growth in the emerging regions in the coming years.
Market Overview and Dynamics
The US home diagnostics for urinary tract infection market is expected to reach US$ 444.91 million by 2027 from US$ 267.44 million in 2019; it is expected to grow at a CAGR of 6.7% from 2020 to 2027. Factors such as growing urinary tract infection prevalence and rising elderly population propel the growth of the market. However, inaccuracy in the results of home UTI screening tests is the major factor hindering the market growth.
Key Market Segments
In terms of form type, the US home diagnostics for urinary tract infection market is segmented into dipsticks, cups, dipslides, cassettes, and others. In 2019, the dipsticks segment held the largest share of the market, and it is further estimated to register the highest CAGR during the forecast period. Based on distribution channel, the US home diagnostics for urinary tract infection market is segmented into retail pharmacies and drug stores, supermarkets/hypermarkets, and online pharmacies. The retail pharmacies and drug stores segment held the largest share of the market in 2019. The market for online pharmacies is expected to grow at the highest CAGR during the forecast period.
Major Sources and Companies Listed
A few of the major primary and secondary sources associated with this report on the US home diagnostics for urinary tract infection market are Chronic Kidney Disease (CKD), National Statistics Institute (NSI), Food and Drug Administration (FDA), and Centers for Disease Control and Prevention (CDC).
Reasons to Buy Report
US Home Diagnostics for Urinary Tract Infection Market
By Form Type
By Distribution Channel
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 267.44 Million |
| Market Size by 2027 | US$ 444.91 Million |
| CAGR (2020 - 2027) | 6.7% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Form Type
|
|
Regions and Countries Covered
|
|
| United States | |
| Market leaders and key company profiles |
|
The US Home Diagnostics for Urinary Tract Infection Market is valued at US$ 267.44 Million in 2019, it is projected to reach US$ 444.91 Million by 2027.
As per our report US Home Diagnostics for Urinary Tract Infection Market, the market size is valued at US$ 267.44 Million in 2019, projecting it to reach US$ 444.91 Million by 2027. This translates to a CAGR of approximately 6.7% during the forecast period.
The US Home Diagnostics for Urinary Tract Infection Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the US Home Diagnostics for Urinary Tract Infection Market report:
The US Home Diagnostics for Urinary Tract Infection Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The US Home Diagnostics for Urinary Tract Infection Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the US Home Diagnostics for Urinary Tract Infection Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)